These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22151792)

  • 41. Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms.
    Tang J; Jones SA; Jeffrey JL; Miranda SR; Galardi CM; Irlbeck DM; Brown KW; McDanal CB; Johns BA
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2689-2694. PubMed ID: 28454672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid.
    Zhou J; Chen CH; Aiken C
    Retrovirology; 2004 Jun; 1():15. PubMed ID: 15225375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants of activity of the HIV-1 maturation inhibitor PA-457.
    Li F; Zoumplis D; Matallana C; Kilgore NR; Reddick M; Yunus AS; Adamson CS; Salzwedel K; Martin DE; Allaway GP; Freed EO; Wild CT
    Virology; 2006 Dec 5-20; 356(1-2):217-24. PubMed ID: 16930665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor.
    Seclén E; González Mdel M; Corral A; de Mendoza C; Soriano V; Poveda E
    AIDS; 2010 Jan; 24(3):467-9. PubMed ID: 19996935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Phosphorus Analogs of Bevirimat: Synthesis, Evaluation of Anti-HIV-1 Activity and Molecular Docking Study.
    Chrobak E; Marciniec K; Dąbrowska A; Pęcak P; Bębenek E; Kadela-Tomanek M; Bak A; Jastrzębska M; Boryczka S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31640137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting Bevirimat resistance of HIV-1 from genotype.
    Heider D; Verheyen J; Hoffmann D
    BMC Bioinformatics; 2010 Jan; 11():37. PubMed ID: 20089140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dimerization of the SP1 Region of HIV-1 Gag Induces a Helical Conformation and Association into Helical Bundles: Implications for Particle Assembly.
    Datta SA; Clark PK; Fan L; Ma B; Harvin DP; Sowder RC; Nussinov R; Wang YX; Rein A
    J Virol; 2016 Feb; 90(4):1773-87. PubMed ID: 26637452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.
    Li F; Goila-Gaur R; Salzwedel K; Kilgore NR; Reddick M; Matallana C; Castillo A; Zoumplis D; Martin DE; Orenstein JM; Allaway GP; Freed EO; Wild CT
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13555-60. PubMed ID: 14573704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and the inhibitors].
    Jiang Y; Liu XY
    Yao Xue Xue Bao; 2010 Feb; 45(2):205-14. PubMed ID: 21351430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preservation of HIV-1 Gag Helical Bundle Symmetry by Bevirimat Is Central to Maturation Inhibition.
    Pak AJ; Purdy MD; Yeager M; Voth GA
    J Am Chem Soc; 2021 Nov; 143(45):19137-19148. PubMed ID: 34739240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.
    Spearman P
    Curr Top Med Chem; 2016; 16(10):1154-66. PubMed ID: 26329615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3-O-(3',3'-dimethysuccinyl) betulinic acid inhibits maturation of the human immunodeficiency virus type 1 Gag precursor assembled in vitro.
    Sakalian M; McMurtrey CP; Deeg FJ; Maloy CW; Li F; Wild CT; Salzwedel K
    J Virol; 2006 Jun; 80(12):5716-22. PubMed ID: 16731910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors.
    Qian K; Bori ID; Chen CH; Huang L; Lee KH
    J Med Chem; 2012 Sep; 55(18):8128-36. PubMed ID: 22978745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.
    Nangola S; Urvoas A; Valerio-Lepiniec M; Khamaikawin W; Sakkhachornphop S; Hong SS; Boulanger P; Minard P; Tayapiwatana C
    Retrovirology; 2012 Feb; 9():17. PubMed ID: 22348230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug evaluation: bevirimat--HIV Gag protein and viral maturation inhibitor.
    Temesgen Z; Feinberg JE
    Curr Opin Investig Drugs; 2006 Aug; 7(8):759-65. PubMed ID: 16955688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling the full length HIV-1 Gag polyprotein reveals the role of its p6 subunit in viral maturation and the effect of non-cleavage site mutations in protease drug resistance.
    Su CT; Kwoh CK; Verma CS; Gan SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4366-4377. PubMed ID: 29237328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.
    Lee SK; Harris J; Swanstrom R
    J Virol; 2009 Sep; 83(17):8536-43. PubMed ID: 19515760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of potent maturation inhibitors against HIV-1 clade C.
    Timilsina U; Ghimire D; Timalsina B; Nitz TJ; Wild CT; Freed EO; Gaur R
    Sci Rep; 2016 Jun; 6():27403. PubMed ID: 27264714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maturation inhibitors facilitate virus assembly and release of HIV-1 capsid P224 mutant.
    Timilsina U; Ghimire D; Adhikari LP; Bhattarai A; Mishra N; Rai M; Dubey RC; Gaur R
    Virology; 2018 Aug; 521():44-50. PubMed ID: 29879541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation.
    Schur FK; Obr M; Hagen WJ; Wan W; Jakobi AJ; Kirkpatrick JM; Sachse C; Kräusslich HG; Briggs JA
    Science; 2016 Jul; 353(6298):506-8. PubMed ID: 27417497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.